Skip to main content ( press enter )

Search

Reset filter
Displaying results 1020 - 1026 of 1171
Management of the deteriorating patient in the community 
Our patients may become unwell due to their disease or treatment while in the community. Without urgent assessment and intervention this can be life threatening.  Patients may be immunocompromised and may not display the... Read more
How machine learning is helping patients diagnosed with the most common childhood cancer
How machine learning is helping patients diagnosed with the most common childhood cancer
New software developed by Peter Mac and collaborators is helping patients diagnosed with acute lymphoblastic leukaemia (ALL) to determine what subtype they have. ALL is the most common childhood... Read more
Small molecule therapeutics
Peter Mac excels in discovering new cancer pathways and translating them into first‑in‑class small‑molecule therapeutics, powered by leading‑edge biology expertise, robust translational models and strong medicinal... Read more
Parkville Cancer Clinical Trials Unit
Improving patient communication in clinical trials
Entering a clinical trial for cancer treatment can be a complex decision for patients.   The Parkville Cancer Clinical Trials Unit (PCCTU) worked with the Health Services Research Team at Peter Mac to uncover ways to... Read more
Peter Mac research expertise on show at major cancer conference
Peter Mac research expertise on show at major cancer conference
Peter Mac research has been well-represented at the American Association of Cancer Research (AACR) Annual Meeting, held in New Orleans last week. Lead genitourinary medical oncologist Associate... Read more
67 Peter Mac researchers among world’s most cited scientist
Sixty-seven Peter Mac researchers have been recognised among the top two per cent of most-cited scientists worldwide, according to the newly released Stanford/Elsevier Top 2% Scientists List for 2025. This prestigious annual... Read more
Back to top